Advertisement
Trending - Altmetric
-
Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)
-
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
-
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
-
Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers